Dr. Daniel Bustamante, MD

NPI: 1134411333
Total Payments
$266.80
2024 Payments
$13.35
Companies
7
Transactions
8

Payment Breakdown by Category

Food & Beverage$230.85 (86.5%)
Education$35.95 (13.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $230.85 7 86.5%
Education $35.95 1 13.5%

Top Paying Companies

Company Total Records Latest Year
Alexion Pharmaceuticals, Inc. $137.65 2 $0 (2018)
Medtronic, Inc. $35.16 1 $0 (2023)
bioMerieux Inc $30.09 1 $0 (2023)
Adaptive Biotechnologies Corporation $20.74 1 $0 (2022)
Janssen Biotech, Inc. $16.77 1 $0 (2022)
AstraZeneca Pharmaceuticals LP $13.35 1 $0 (2024)
Ortho-Clinical Diagnostics, Inc. $13.04 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $13.35 1 AstraZeneca Pharmaceuticals LP ($13.35)
2023 $65.25 2 Medtronic, Inc. ($35.16)
2022 $37.51 2 Adaptive Biotechnologies Corporation ($20.74)
2018 $150.69 3 Alexion Pharmaceuticals, Inc. ($137.65)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/16/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $13.35 General
Category: Oncology
11/17/2023 Medtronic, Inc. STEALTHSTATION S8 PLATFORM (Device) Food and Beverage In-kind items and services $35.16 General
Category: Image Guided Surgery Products
11/16/2023 bioMerieux Inc Food and Beverage In-kind items and services $30.09 General
10/15/2022 Janssen Biotech, Inc. IMBRUVICA (Drug) Food and Beverage In-kind items and services $16.77 General
Category: Oncology
03/30/2022 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage In-kind items and services $20.74 General
Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
06/15/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $101.70 General
Category: Immunology
05/17/2018 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Education In-kind items and services $35.95 General
Category: Immunology
04/23/2018 Ortho-Clinical Diagnostics, Inc. Food and Beverage In-kind items and services $13.04 General

About Dr. Daniel Bustamante, MD

Dr. Daniel Bustamante, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in El Paso, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2011. The National Provider Identifier (NPI) number assigned to this provider is 1134411333.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Bustamante, MD has received a total of $266.80 in payments from pharmaceutical and medical device companies, with $13.35 received in 2024. These payments were reported across 8 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($230.85).

Practice Information

  • Specialty Anatomic Pathology & Clinical Pathology
  • Other Specialties Hematology, Anatomic Pathology & Clinical Pathology
  • Location El Paso, TX
  • Active Since 05/05/2011
  • Last Updated 11/05/2019
  • Taxonomy Code 207ZP0102X
  • Entity Type Individual
  • NPI Number 1134411333

Products in Payments

  • SOLIRIS (Drug) $137.65
  • STEALTHSTATION S8 PLATFORM (Device) $35.16
  • clonoSEQ (Device) $20.74
  • IMBRUVICA (Drug) $16.77
  • ENHERTU (Biological) $13.35

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Anatomic Pathology & Clinical Pathology Doctors in El Paso